Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10297 |
| Vaccine Name | HSV15 |
| Disease Name | Genital Herpes |
| Disease Classification | Cutaneous |
| Virus Name | Herpes simplex virus |
| Nucleic Acid Content | double stranded DNA |
| Vaccine Type | Subunit vaccine |
| Vaccine Status | Phase 2 |
| Manufacturer | Sanofi Pasteur |
| Year of Manufacturing | 2021 |
| Manufacturing Country | USA |
| Age | 18 - 55 years |
| Dosage | NA |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | Wild-type HSV virus components except two proteins UL5 and UL29 |
| Description | NA |
| Approving Organisation | US FDA |
| Collaborating Organisation | National Institute of Allergy and Infectious Diseases |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT04222985 |
| Reference Link | https://www.precisionvaccinations.com/vaccines/herpes-vaccine-candidates |
| Additional Links | https://clinicaltrials.gov/ct2/show/NCT04222985 |